title: Myocardin functions as an effective inducer of growth arrest and differentiation in human uterine leiomyosarcoma cells.
abstract: Myocardin is an important transcriptional regulator in smooth and cardiac muscle development. We noticed that the expression of myocardin was markedly downregulated in human uterine leiomyosarcoma cells. Restoration of myocardin expression induced the reexpression of smooth muscle marker proteins and the formation of well-developed actin fibers. A concomitant increase in the expression of a cyclin-dependent kinase inhibitor, p21, led to significantly reduced cell proliferation, via p21's inhibition of the G(1)-S transition. A p21 promoter-reporter assay showed that myocardin markedly increased p21's promoter activity. Furthermore, a serum response factor (SRF)-binding cis-element CArG box in the p21 promoter region was required for this myocardin effect. Chromatin immunoprecipitation and DNA-protein binding assays showed that myocardin indirectly bound to the CArG box in the p21 promoter through the interaction with SRF. Furthermore, immunohistochemistry revealed that the levels of myocardin and p21 were both lower in leiomyosarcoma samples than in normal smooth muscle tissue. Taken together, our results indicate that the downregulation of myocardin expression facilitates cell cycle progression via the reduction of p21 expression in human leimyosarcomas and suggest that myocardin could be a useful therapeutic target for this disease.
authors.affiliation: Department of Neuroscience, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Kimura
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Morita
authors.forename: Ken'ichiro
authors.initials: K
authors.lastname: Hayashi
authors.forename: Tsuneharu
authors.initials: T
authors.lastname: Miki
authors.forename: Kenji
authors.initials: K
authors.lastname: Sobue
mesh_terms: D002454:Cell Differentiation; D048708:Cell Growth Processes; D045744:Cell Line, Tumor; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000096:biosynthesis / Q000235:genetics; D005260:Female; D016193:G1 Phase / Q000502:physiology; D006801:Humans; D007890:Leiomyosarcoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D009130:Muscle, Smooth / Q000473:pathology; D009687:Nuclear Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D010641:Phenotype; D011401:Promoter Regions, Genetic; D016196:S Phase / Q000502:physiology; D015534:Trans-Activators / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D015533:Transcriptional Activation; D015854:Up-Regulation; D014594:Uterine Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D000099251:Myocardin
chemical_list: D050759:Cyclin-Dependent Kinase Inhibitor p21; D009687:Nuclear Proteins; D015534:Trans-Activators; D000099251:Myocardin; C493956:CDKN1A protein, human